ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies

University of Utah · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
high risk hematologic malignancies, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 992175
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.